v3.26.1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2026
Net Loss Per Share  
Schedule of anti-dilutive securities excluded from the computation of diluted net loss per share

March 31,

2026

2025

Options to purchase common stock

10,988,118

8,670,569

Unvested RSUs

667,600

Common stock to be issued to InnoCare

2,000,000

Shares of common stock underlying convertible senior notes outstanding1

7,547,160

1 Represents conversion rate, as of March 31, 2026, of 37.7358 shares of common stock per $1,000 principal amount of notes.